Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > TLT lost about 50% of its value this year....
View:
Post by newdaydawning on Dec 31, 2020 3:55pm

TLT lost about 50% of its value this year....

...would be nice to recoup that value in the coming year. All the best to TLT faithful in 2021.
Comment by robertshaw on Dec 31, 2020 4:02pm
Lost 50% of the value, Thanks to idiot RDW.
Comment by Oden6570 on Dec 31, 2020 4:17pm
Well a positive in my opinion at least for me is tommorrow i get to transfer 31578 shares from my cash account into my TFSA : - ) I am at the same time dissapointed that we did not begin animal covid testing as indicated. Perhaps covid lockdowns etc have delayed us again.
Comment by Pandora on Dec 31, 2020 6:47pm
Yes, I had that same benefit a couple or more years back and am still waiting for the opportunity to capitalize on it. In the meantime a couple others that I left in my margin account  have done better - and of course they're taxable. It's the old dart board approach - throw the dart and see where it lands. We'll try it again next week. :-))
Comment by Yajne on Dec 31, 2020 10:37pm
As for me, I'm planning to add more next week to start the year. I had a false start several months ago by adding before initial Ph2 results came out, small disaster, sold those that I had added and fortunately was able to more than recoup those losses on HPQ. I have always kept my base TLT intact. IMO they have now corrected their mishaps and with news pending in the coming weeks, it is now ...more  
Comment by Retireyoung on Jan 01, 2021 1:21pm
I'm going to do the same. Adding 22,000 more shares in my tfsa. I will be at 200,000 shares at that point and that is it for me. Hopefully this is the year as I am pretty sick of working for a living.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250